Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
AffaMed Therapeutics
company
About
AffaMed Therapeutics is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products.
- New City,New York,United States
- 101 - 250
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $170M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2019
- Number Of Employee
- 101 - 250
- Operating Status
- Active
AffaMed Therapeutics is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$170M
AffaMed Therapeutics has raised a total of
$170M
in funding over 2 rounds. Their latest funding was raised on
Mar 30, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 30, 2021 | Series B | $170M | 6 |
Lake Bleu Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
6
AffaMed Therapeutics is funded by 6 investors.
Lake Bleu Capital
and Superstring Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Lake Bleu Capital
|
Yes | Series B |
|
|
— | Series B |
CBC Investment Group
|
— | Series B |
Fountainhead Investment Partners
|
— | Series B |
Orion Capital Group, Inc.
|
— | Series B |
Partners Investment
|
— | Series B |
Employee Profiles
Number of Employee Profiles
4
AffaMed Therapeutics has 4 current employee profiles, including
Executive Michael Keyoung
Acquisition
AffaMed Therapeutics has acquired 1 organizations. Their most recent acquisition was EverInsight Therapeutics on Oct 14, 2020. They acquired EverInsight Therapeutics for 0.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Oct 14, 2020
|
Biotechnology | merge | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
